LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)

Stopped early · Phase 2

Conditions studied: Acne, Post Inflammatory Hyperpigmentation

In brief

The purpose of this research study is to measure the depigmenting effect of a serum product called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper Pigmentation)

Key facts

Study ID: NCT05327361
Run by: University of Miami
People needed: 13
Starts: 2022-03-22
Expected to finish: 2023-03-06
Last updated by the study team: 2024-04-03

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Multiethnic subjects
18 to 50 YO
Phototype III-VI
All skin types
50% with sensitive skin (declarative)
Symmetrical mild to moderate facial post-acne PIHP lesions with IGA scale
Mild active acne (less than 10 retention and 5 inflammatory lesions)
Agreeing not to change their lifestyle during the study period.
Capable of reading the documents presented to them, of adhering to the study regulations and accepting the limitations.
Available to follow the study
Agreeing to participate and having signed the informed consent

You may not qualify if…

Moderate to severe active acne
Patients under topical or systemic retinoids
Patients under systemic immunosuppressants
Patients under active treatment of PIHP (including topicals or procedures) within the last 3 months
Patients treated with facial procedures within the last 3 months
Pregnancy
Patient with a recent change in contraception (since less than 6 months)
Known allergy to any component of tested product
Not presenting with the conditions needed to comply with the protocol.
Unable to give their informed consent
Not available to follow the study in its entirety

Where it is running

University of Miami Hospital — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.